Canton Strategic Holdings (CNTN) Change in Cash (2021 - 2026)
Canton Strategic Holdings (CNTN) posted Change in Cash of $24.5 million for Q1 2026, up 160.01% on a QoQ basis from $9.4 million in Q4 2025, and up 1086.51% year-over-year from $2.1 million in Q1 2025.
Canton Strategic Holdings (CNTN) Change in Cash (2021 - 2026) Analysis & Trends
Canton Strategic Holdings' Change in Cash history runs 6 years deep, the most recent figure standing at $24.5 million for Q1 2026.
- Quarterly Change in Cash rose 1086.51% year-over-year to $24.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.5 million (up 650.32% YoY) and the FY2025 annual result came in at $13.5 million, up 282.67% from the prior year.
- Change in Cash was $24.5 million for Q1 2026 at Canton Strategic Holdings, up from $9.4 million in the prior quarter.
- Across five years, Change in Cash topped out at $24.5 million in Q1 2026 and bottomed at -$3.1 million in Q3 2024.
- A 5-year average of $2.4 million and a median of -$1.1 million in 2022 frame the typical range for Change in Cash.
- Peak annual rise in Change in Cash reached 6665.0% in 2022, while the deepest fall reached 24311.56% in 2022.
- Canton Strategic Holdings' Change in Cash stood at -$1.1 million in 2022, then surged by 859.23% to $8.2 million in 2023, then tumbled by 114.73% to -$1.2 million in 2024, then jumped by 875.59% to $9.4 million in 2025, then surged by 160.01% to $24.5 million in 2026.
- Business Quant data shows CNTN's Change in Cash at $24.5 million in Q1 2026, $9.4 million in Q4 2025, and $5.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Canton Strategic Holdings | 427.87 Mn | 427.87 Mn | - | 24.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.50 Mn |
| Dec 31, 2025 | 9.42 Mn |
| Sep 30, 2025 | 5.37 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | -2.48 Mn |
| Dec 31, 2024 | -1.21 Mn |
| Sep 30, 2024 | -3.12 Mn |
| Jun 30, 2024 | -531,463.00 |
| Mar 31, 2024 | -2.51 Mn |
| Dec 31, 2023 | 8.25 Mn |
| Sep 30, 2023 | -1.21 Mn |
| Jun 30, 2023 | 334,825.00 |
| Mar 31, 2023 | -2.94 Mn |
| Dec 31, 2022 | -1.09 Mn |
| Sep 30, 2022 | -1.89 Mn |
| Jun 30, 2022 | -1.64 Mn |
| Mar 31, 2022 | 11.12 Mn |
| Dec 31, 2021 | -40,739.00 |
| Sep 30, 2021 | 15,824.00 |
| Jun 30, 2021 | 6,764.00 |